Pennsylvania Medical Marijuana Sales Reach $10.4 Billion as Active Patient Certifications Rise to 439,124

Pennsylvania’s medical marijuana program has now recorded $10.4 billion in program-to-date sales, while active patient certifications have risen to 439,124, according to new data presented Wednesday to the state’s Medical Marijuana Advisory Board.

The Pennsylvania Department of Health reported the figures as of September 1 during the board’s September 23 meeting.

Active patient certifications increased from 438,727 as of June 1 to 439,124 as of September 1, a gain of 397 over the three-month period.

Program-to-date patient registrations saw a larger increase, climbing from 1,129,606 in June to 1,152,272 in September, an increase of 22,666.

The number of approved medical marijuana practitioners also increased, rising from 1,937 to 1,945.

Pennsylvania now has 200 operational medical marijuana dispensaries, up from 196 in June. The number of operational grower/processors remained unchanged at 33.

Sales have continued to climb. The state reported $10.4 billion in program-to-date marijuana sales as of September 1, compared with $9.6 billion reported as of June 1. Based on the state’s rounded totals, that represents roughly $800 million in additional program sales over the three-month period.

Monthly dispensary sales have remained near historically high levels throughout 2026, with the state’s latest chart showing monthly sales generally around or above $140 million during much of the year.

The latest figures also show marijuana flower prices continuing to decline.

As of August, the average retail price for dry leaf was $7.32 per gram, while the average wholesale price was $2.22 per gram.

For comparison, when the state began tracking the pricing series in January 2021, the average retail price was $14.90 per gram and the average wholesale price was $10.65. Retail prices have fallen by roughly 51% since then, while wholesale prices have declined by approximately 79%.

Financial assistance provided through the Medical Marijuana Assistance Program (MMAP) also increased. Phase 3 benefits have now reached $2,529,507.88, up from $2,268,338 in June, an increase of more than $261,000.

Pennsylvania launched medical marijuana sales in 2018. The program allows registered patients with qualifying medical conditions to purchase marijuana products from licensed dispensaries after receiving a certification from an approved practitioner.